CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-27 | Brooks Michael J President | Purchase | +1,000 | $3.00 | $3K | 4,327 |
| 2020-05-26 | Nijhawan Pardeep Chief Executive Officer | Purchase | +3,000 | $2.98 | $9K | 2,124,024 |
| 2020-03-29 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $5.23 | $10K | 547,312 |
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.89 | $2K | 2,117,024 |
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.86 | $2K | 2,118,024 |
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.90 | $2K | 2,119,024 |
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.83 | $2K | 2,120,024 |
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.90 | $2K | 2,121,024 |
| 2020-02-12 | OAKES FRANK R. Director | Grant or award · Share Option (Right to Buy) | +11,389 | 11,389 | ||
| 2020-02-12 | Brooks Michael J President | Grant or award · Share Option (Right to Buy) | +68,988 | 68,988 | ||
| 2020-02-12 | van der Velden Peter Director | Grant or award · Share Option (Right to Buy) | +11,389 | 11,389 | ||
| 2020-02-12 | JOHNSON LORIN K Director | Grant or award · Share Option (Right to Buy) | +11,389 | 11,389 | ||
| 2020-02-12 | MacDonald Sean Arthur Director | Grant or award · Share Option (Right to Buy) | +11,389 | 11,389 | ||
| 2020-02-12 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +88,699 | 88,699 | ||
| 2020-02-12 | Pay Paul William Director | Grant or award · Share Option (Right to Buy) | +11,389 | 11,389 | ||
| 2020-02-12 | Sistilli Carlo Director | Grant or award · Share Option (Right to Buy) | +11,389 | 11,389 | ||
| 2020-01-08 | van der Velden Peter Director | Grant or award | +128,722 | $3.20 | $412K | 1,833,066 |
| 2020-01-08 | van der Velden Peter Director | Grant or award | +11,903 | $3.20 | $38K | 169,502 |
| 2020-01-08 | van der Velden Peter Director | Grant or award · Common Share Warrants (Right to Buy) | +96,542 | 96,542 | ||
| 2020-01-08 | van der Velden Peter Director | Grant or award · Common Share Warrants (Right to Buy) | +8,928 | 8,928 |
Page 10 of 15 · 284 trades